Illumina to Submit Cytogenetics Package to FDA, Commits to Using Arrays in Dx

The decision marks a shift in strategy for Illumina, which had previously positioned its digital microbead-based BeadXpress reader as its diagnostics platform of choice. Now it will seek FDA clearance for clinical use of its arrays, too.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.